Search clinical trials for: SU011248/Trastuzumab
Total 1276 results
-
Indiana UniversityBreast Cancer Research Foundation; Geron CorporationCompletedBreast NeoplasmsUnited States
-
Genentech, Inc.National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Institut CurieCompletedMetastatic Breast Cancer, HER2 Negative Primary TumorFrance
-
Boehringer IngelheimCompletedBreast NeoplasmsUnited States, Brazil, Colombia, Peru
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Seagen Inc.Active, not recruitingHER2 Positive Breast CancerUnited States
-
Cancer Trials IrelandTerminatedMetastatic Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast CancerIreland, Spain
-
Morten Mau-SørensenOdense University Hospital; Aarhus University Hospital; Aalborg University HospitalRecruitingEsophageal Squamous Cell Carcinoma | HER-2 Gene Amplification | HER-2 Protein OverexpressionDenmark
-
CelltrionCompletedHealthy VolunteersUnited States
-
Institut de cancérologie Strasbourg EuropeNot yet recruitingProtocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C) (PHARE-C)HER2-positive Breast Cancer
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon Small Cell Lung Cancer Metastatic | HER2 Gene Mutation | Non Small Cell Lung Cancer Stage IIIFrance
-
Nancy Lin, MDGenentech, Inc.Active, not recruitingHER2-positive Metastatic Breast Cancer | Central Nervous System MetastasesUnited States
-
NSABP Foundation IncPfizerCompleted
-
Swiss Group for Clinical Cancer ResearchCompletedMetastatic Breast CancerFrance, Switzerland, Netherlands, Germany
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.RecruitingLung Cancer | Bladder Cancer | Solid Tumor Cancers | Urinary Tract CancersUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Malignancies | Hematologic MalignanciesUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
WiSP Wissenschaftlicher Service Pharma GmbHBristol-Myers Squibb; Roche Pharma AGCompleted
-
SanofiCompletedBreast NeoplasmsFrance, Brazil, Poland, Germany, Belgium, Tunisia, United Kingdom, Uruguay
-
Korean Cancer Study GroupUnknownPhase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast CancerMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsTerminatedBreast Cancer | Metastatic Breast CancerUnited States
-
Genentech, Inc.Completed
-
National Cancer Institute, NaplesCompletedMetastatic Breast Cancer
-
AstraZenecaRecruitingAdvanced Solid MalignanciesUnited States, Korea, Republic of, Spain, Australia, Sweden, Germany, United Kingdom
-
Gruppo Oncologico Italiano di Ricerca ClinicaMipharm SpA; Temas srl; Clirest s.r.l.; University Hospital of Parma: Department... and other collaboratorsUnknown
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.Completed
-
Shandong UniversityUnknownHER2-positive Breast Cancer
-
Cancer Institute and Hospital, Chinese Academy...RecruitingCarcinoma, Transitional Cell | HER-2 Gene AmplificationChina
-
University of WashingtonActive, not recruitingHER2-positive Breast CancerUnited States
-
AryoGen Pharmed Co.Completed
-
The Netherlands Cancer InstituteAstraZenecaActive, not recruitingBreast CancerNetherlands
-
Taizhou Mabtech Pharmaceutical Co.,LtdCompletedHealthy VolunteersChina
-
Hoffmann-La RocheCompleted
-
Ashkan EmadiCompletedAcute Myeloid LeukemiaUnited States
-
Hoffmann-La RocheTerminated
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheTerminatedGastric CancerGermany, Austria
-
CelltrionNippon Kayaku Co., Ltd.CompletedHER2-positive Carcinoma of BreastItaly, South Africa, Mexico, Japan, Taiwan, Russian Federation, Philippines, Hungary, Romania, Spain, Bosnia and Herzegovina, India, Peru, Ukraine, Latvia, Argentina, Georgia, Belarus, Chile, France, Poland, Portugal
-
Hoffmann-La RocheCompletedBreast NeoplasmsHungary, Italy, United Kingdom, Canada, Czechia, Bulgaria, Croatia, Dominican Republic, France, Germany, Greece, Guatemala, Hong Kong, Indonesia, Ireland, Korea, Republic of, Netherlands, Panama, Peru, Poland, Portugal, Slovakia, Spain and more
-
Novartis PharmaceuticalsTerminatedAdvanced Gastric CancerSpain, Belgium, France, Italy, United States, Korea, Republic of, Japan, Germany
-
Hoffmann-La RocheCompleted
-
Institut CurieCentre Leon Berard; Institut Bergonié; Hoffmann-La Roche; University Hospital,... and other collaboratorsCompletedMetastatic Breast Cancer | Carcinomatous MeningitisFrance
-
Hoffmann-La RocheCompletedGastric Cancer, Gastroesophageal Junction CancerFrance
-
Maastricht University Medical CenterCompleted
-
ARCAGY/ GINECO GROUPHoffmann-La RocheTerminated
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.Recruiting